HiResolution Bionic Ear System Ultra and Ultra 3D Thin PCB
Advanced Bionics · Decision date Apr 9, 2026
What did the FDA decide?
FDA records P960058/S174 as a supplement to PMA P960058, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 9, 2026.
FDA approval order statement
approval of an alternate flex layer on the printed circuit board used for the implants in the HiResolution Bionic Ear System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Apr 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P960058/S174
- Regulatory pathway
- PMA supplement
- Applicant
- Advanced Bionics
- Product code
- MCM
- Decision code
- OK30
- Decision date
- Apr 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, cochlear.
- Applicant
- Advanced Bionics
- Product code
- MCM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P960058. Subsequent supplements may change the device or its indications.
FDA decision timeline
P960058 · Original PMA
CLARION MULTI-STRATEGY COCHLEAR IMPLANT
P960058/S171 · Related supplement
HiResolution Bionic Ear System
P960058/S172 · Related supplement
HiResolution Bionic Ear System
P960058/S170 · Related supplement
HiResolution Bionic Ear System
P960058/S174 received
Application receipt date recorded by FDA.
P960058/S174 · FDA decision
30-Day Notice
P960058/S173 · Related supplement
HiResolution Bionic Ear System
P960058/S175 · Related supplement
HiResolution Bionic Ear System
P960058/S167 · Related supplement
HiResolution Bionic Ear System
P960058/S177 · Related supplement
HiResolution Bionic Ear System
P960058/S178 · Related supplement
CLARION MULTI-STRATEGY COCHLEAR IMPLANT
Timeline entries are records held by MedtechLedger for P960058. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960058
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Advanced Bionics | PMA approval | Jun 26, 1997 | FDA | |
HiResolution Bionic Ear SystemP960058/S171 | Advanced Bionics | PMA supplement | Aug 20, 2025 | FDA |
HiResolution Bionic Ear SystemP960058/S172 | Advanced Bionics | PMA supplement | Oct 14, 2025 | FDA |
HiResolution Bionic Ear SystemP960058/S170 | Advanced Bionics | PMA supplement | Jan 23, 2026 | FDA |
HiResolution Bionic Ear SystemP960058/S173 | Advanced Bionics | PMA supplement | Apr 16, 2026 | FDA |
HiResolution Bionic Ear SystemP960058/S175 | Advanced Bionics | PMA supplement | Apr 16, 2026 | FDA |
HiResolution Bionic Ear SystemP960058/S167 | Advanced Bionics | PMA supplement | Jul 22, 2026 | FDA |
HiResolution Bionic Ear SystemP960058/S177 | Advanced Bionics | PMA supplement | Sep 4, 2026 | FDA |
CLARION MULTI-STRATEGY COCHLEAR IMPLANTP960058/S178 | Advanced Bionics | PMA supplement | Sep 18, 2026 | FDA |
Explore the linked device profile
Other records with product code MCM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MED-EL Cochlear Implant SystemP000025/S136 | Med-El Corp. | PMA supplement | Oct 9, 2026 | FDA |
Nucleus 22 Cochlear Implant SystemP840024/S099 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Nucleus 22 Cochlear Implant SystemP890027/S067 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Nucleus 24 Cochlear Implant SystemP970051/S244 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Nucleus 24 Cochlear Implant SystemP970051/S242 | Cochlear Americas | PMA supplement | Apr 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Advanced Bionics
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 28515 Westinghouse Pl., Valencia, CA, 91355
Sources and methodology
- Original FDA record: P960058/S174
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






